SpyGlass Pharma, Inc. SGP
Set alert
34.70 USD +1.06 +3.15%
As of Nov 3, 10:18 AM ET
34.08 Day range 34.79
17.06 52-week range 34.79
- YTD
- +31.44%
- 1 year
- +31.44%
- Open
- 34.08
- Prev close
- 33.64
- Mkt cap
- 1.15B
- Vol
- 19.97K
- Avg vol
- 102.06K
- EPS
- -2.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 34.08
- High
- 34.79
- Forward P/E
- -11.95
- Beta
- 0.00
- Short ratio
- 9.43
- Inst. own
- 94.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 27.23
- 200-d avg
- 24.36
- 1y target
- 44.00
5m chart
Built from the cached five-day intraday bars.
Signals (136)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 10:10 AM | 1 day ago |
| RSI: Overbought | Nov 2, 9:40 AM | 1 day ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:00 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 3 days ago |
Newest 20 of 136.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 44.00 +26.8% upside
Now 34.70
- Target (low)
- 37.00
- Target (mean)
- 44.00
- Target (high)
- 62.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.62247 | -0.71 – -0.52481 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Next quarter | -0.65294 | -0.77 – -0.54762 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Current year | -2.50 | -2.57 – -2.31 | -1.96 | -27.5% | 0 | 0.0% | 6 |
| Next year | -2.81 | -3.45 – -1.95 | -2.50 | -12.6% | 0 | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 5, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2026 | Raymond James | Initiated | — | Outperform |
| Mar 10, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 3, 2026 | Citigroup | Initiated | — | Buy |
| Mar 3, 2026 | Leerink Partners | Initiated | — | Outperform |
| Mar 3, 2026 | Jefferies | Initiated | — | Buy |
| Mar 3, 2026 | Stifel | Initiated | — | Buy |